Company poised to implement Remote Monitoring Patient Programs with Several Large U.S. and European Health Organizations SUN VALLEY, Calif., Aug. 18
SUN VALLEY, Calif., Aug. 18 /PRNewswire-FirstCall/ -- XTend Medical
Corporation (OTC Pink Sheets: XMDC), a company that delivers cutting-edge
telemedicine solutions to the healthcare industry, has secured up to $1
million dollars in financing for their upcoming implementation of their Remote
Diabetic Monitoring Programs with several large U.S. and European Health
Organizations.
The company released the following statement:
"XTend Medical recently secured a $1 million dollar financing package
designed to assist us in the implementation of our Remote Patient Monitoring
System for Diabetes. This allows us to focus 100% on insuring the pending
closure of several contracts over the next 30 days will be done with less
financial strain on the company and allows us to purchase our products on
favorable pricing thereby increasing our profit margins for the company. We've
worked very hard over the last six months in marketing our products globally
and this financing creates the opportunity for the company to focus on gaining
additional contracts here in the U.S. and in the European Market. Our Remote
Diabetic Patient Monitoring Program has been well received thus far with the
patients and physicians we currently work with and we've had several large
health organizations both here in the U.S. and in Europe express a deep
interest in starting programs for their patients. We're poised and ready to
capitalize on these opportunities and should see a significant increase in
patients on the program by the end of the year." stated Mr. Paul D. Lisenby,
CEO of XTend Medical
For any healthcare agency of physician group that would like to find more
about the how XTend can assist in your management of diabetic patients, please
visit the company website at http://www.xtendmedical.com or email us at
info@xtendmedical.com
About XTend Medical: XTend Medical Corporation markets and sells
healthcare and wellness products to hospitals, managed care companies, nursing
homes, physician groups and individual patients. XTend has developed a
complete Remote Diabetic Patient Monitoring System that is currently being
used by physicians and other healthcare agencies throughout the U.S. Through
their alliances, XTend offers pharmacy services, diabetic supplies, and
telemedicine products that increase patient care yet reduce costs associated
with servicing those patients. For more information, please visit their
website at http://www.xtendmedical.com
Safe Harbor
This press release contains or may contain forward-looking statements such
as statements regarding the Company's growth and profitability, growth
strategy, liquidity and access to public markets, operating expense reduction,
and trends in the industry in which the Company operates. The forward-looking
statements contained in this press release are also subject to other risks and
uncertainties, including those more fully described in the Company's filings
with the Securities and Exchange Commission. The Company assumes no obligation
to update these forward-looking statements to reflect actual results, changes
in risks, uncertainties or assumptions underlying or affecting such
statements, or for prospective events that may have a retroactive effect.
SOURCE XTend Medical
